139 related articles for article (PubMed ID: 152445)
21. [Functional and diagnostic significance of A-, Bbeta 1-42 and Bbeta 15-42 peptide fragments of fibrin(ogen)].
Makogonenko EM; Lugovskoĭ EV; Kolesnik LA; Kudinov SA
Ukr Biokhim Zh (1978); 1992; 64(4):78-82. PubMed ID: 1448878
[TBL] [Abstract][Full Text] [Related]
22. On the identity of fibrin(ogen) oligomers appearing during fibrin polymerization.
Henschen A
Adv Exp Med Biol; 1990; 281():49-53. PubMed ID: 2102625
[No Abstract] [Full Text] [Related]
23. The effects of ancrod, the coagulating enzyme from the venom of Malayan pit viper (A. rhodostoma) on prothrombin and fibrinogen metabolism and fibrinopeptide A release in man.
Bell WR; Shapiro SS; Martinez J; Nossel HL
J Lab Clin Med; 1978 Apr; 91(4):592-604. PubMed ID: 641385
[TBL] [Abstract][Full Text] [Related]
24. The intravascular generation of fibrinogen derivatives and the blood vessel wall in venous thrombosis and disseminated intravascular coagulation.
Stewart GJ
Thromb Haemost; 1977 Dec; 38(4):831-49. PubMed ID: 146274
[TBL] [Abstract][Full Text] [Related]
25. Fibrinogen Geneva, a new case of A alpha 16 Arg----Cys dysfibrinogenaemia.
Furlan M; Bögli C; Hofer A; Bouvier CA; de Moerloose P
Blood Coagul Fibrinolysis; 1990 Jun; 1(2):139-43. PubMed ID: 2130925
[TBL] [Abstract][Full Text] [Related]
26. Do coagulation screening tests detect increased generation of thrombin and plasmin in sick newborn infants?
Schmidt B; Vegh P; Johnston M; Andrew M; Weitz J
Thromb Haemost; 1993 May; 69(5):418-21. PubMed ID: 8322263
[TBL] [Abstract][Full Text] [Related]
27. Fibrinogen Bergamo I (A alpha 16Arg----Cys): susceptibility towards thrombin following aminoethylation, methylation or carboxamidomethylation of cysteine residues.
Reber P; Furlan M; Beck EA; Finazzi G; Buelli M; Barbui T
Thromb Haemost; 1985 Aug; 54(2):390-3. PubMed ID: 4082078
[TBL] [Abstract][Full Text] [Related]
28. The effect of temperature on formation of fibrin complexes.
Edgar W; Prentice CR
Thromb Res; 1980 Jun; 18(6):759-72. PubMed ID: 6158115
[No Abstract] [Full Text] [Related]
29. Measurement of soluble fibrin monomer-fibrinogen complex in plasmas derived from patients with various underlying clinical situations.
Nakahara K; Kazahaya Y; Shintani Y; Yamazumi K; Eguchi Y; Koga S; Wada H; Matsuda M
Thromb Haemost; 2003 May; 89(5):832-6. PubMed ID: 12719780
[TBL] [Abstract][Full Text] [Related]
30. [Thrombin-fibrinogen interaction: release of fibrinopeptides and the effects of ATP].
Gurrieri MA
Medicina (Firenze); 1990; 10(1):51-2. PubMed ID: 2381284
[TBL] [Abstract][Full Text] [Related]
31. Determination of human fibrinopeptide A by radioimmunoassay in purified systems and in the blood.
Budzynski AZ; Marder VJ
Thromb Diath Haemorrh; 1975 Dec; 34(3):709-17. PubMed ID: 1209541
[TBL] [Abstract][Full Text] [Related]
32. Fibrinogen and fibrin: biochemistry and pathophysiology.
Budzynski AZ
Crit Rev Oncol Hematol; 1986; 6(2):97-146. PubMed ID: 2878736
[TBL] [Abstract][Full Text] [Related]
33. Unique pattern of fibrinogen cleavage by human leukocyte proteases.
Bilezikian SB; Nossel HL
Blood; 1977 Jul; 50(1):21-8. PubMed ID: 871524
[No Abstract] [Full Text] [Related]
34. The occurrence and clinical relevance of fibrin fragments in blood.
Gaffney PJ
Ann N Y Acad Sci; 1983 Jun; 408():407-23. PubMed ID: 6575697
[No Abstract] [Full Text] [Related]
35. Fibrinopeptide A in the diagnosis and treatment of deep venous thrombosis and pulmonary embolism.
Joist JH
Clin Lab Med; 1984 Jun; 4(2):363-80. PubMed ID: 6499399
[TBL] [Abstract][Full Text] [Related]
36. [Diagnostic significance of proteolytic breakdown products of fibrinogen and fibrin].
Heene DL; Genth K
Internist (Berl); 1984 Feb; 25(2):93-101. PubMed ID: 6231262
[No Abstract] [Full Text] [Related]
37. Fibrinogen and its derivatives in intravascular coagulation. A review.
Gerrits WB
Neth J Med; 1975; 18(1):31-44. PubMed ID: 124019
[No Abstract] [Full Text] [Related]
38. Measurement of crosslinked fibrin degradation products - an immunoassay using monoclonal antibodies.
Elms MJ; Bunce IH; Bundesen PG; Rylatt DB; Webber AJ; Masci PP; Whitaker AN
Thromb Haemost; 1983 Aug; 50(2):591-4. PubMed ID: 6356456
[TBL] [Abstract][Full Text] [Related]
39. Use of fibrinopeptide A measurements in the diagnosis and management of thrombosis.
Nossel HL
Adv Exp Med Biol; 1975; 63():255-64. PubMed ID: 1199866
[No Abstract] [Full Text] [Related]
40. The clinical significance of fibrinogen degradation products.
Bick RL
Semin Thromb Hemost; 1982 Oct; 8(4):302-30. PubMed ID: 6758120
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
